Ligand Pharma (LGND) PT Raised to $340 at RBC Capital Jul 15, 2026 09:55AM
Ligand to Participate in May Investor Conferences May 5, 2026 04:01PM
Ligand Pharma (LGND) PT Raised to $252 at RBC Capital Apr 28, 2026 05:06AM
RBC Capital Reiterates Outperform Rating on Ligand Pharma (LGND), Investor Day Preview Nov 25, 2025 07:40AM
Ligand Pharma (LGND) PT Raised to $234 at RBC Capital Nov 10, 2025 07:46AM


Aug 8, 2025 08:49AM Ligand Pharma (LGND) PT Raised to $185 at RBC Capital
May 1, 2025 07:00AM Ligand to Participate in May Investor Conferences
Feb 28, 2025 09:31AM Ligand Pharma (LGND) PT Raised to $153 at RBC Capital Following a 'Strong Quarter'
Dec 11, 2024 07:55AM Ligand Pharma (LGND) PT Raised to $143 at RBC Capital
Dec 3, 2024 08:09AM Ligand Pharma (LGND) PT Raised to $141 at RBC Capital Ahead of Investor Day
Jul 30, 2024 03:16AM RBC Capital Starts Ligand Pharma (LGND) at Outperform
Jan 22, 2009 10:05AM Notable Analyst Rating Changes 1/22: BBY, AAP, ERIC, M Upgraded; DOX, MRVL, K, WYE Downgraded